HUTCHMED (China) Limited
HMDCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $630 | $838 | $426 | $356 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Cost of Goods Sold | $349 | $384 | $311 | $258 |
| Gross Profit | $281 | $454 | $115 | $98 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| R&D Expenses | $212 | $302 | $391 | $315 |
| G&A Expenses | $64 | $80 | $92 | $89 |
| SG&A Expenses | $113 | $133 | $136 | $127 |
| Sales & Mktg Exp. | $49 | $53 | $44 | $38 |
| Other Operating Expenses | -$3 | -$3 | -$5 | -$16 |
| Operating Expenses | $322 | $432 | $523 | $426 |
| Operating Income | -$41 | $18 | -$413 | -$343 |
| % Margin | -6.4% | 2.2% | -96.9% | -96.2% |
| Other Income/Exp. Net | $86 | $87 | $52 | $188 |
| Pre-Tax Income | $45 | $106 | -$362 | -$155 |
| Tax Expense | $7 | $5 | -$0 | $12 |
| Net Income | $38 | $101 | -$361 | -$195 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS | 0.044 | 0.12 | -0.43 | -0.24 |
| % Growth | -63.3% | 127.9% | -79.2% | – |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.24 |
| Weighted Avg Shares Out | 855 | 850 | 847 | 793 |
| Weighted Avg Shares Out Dil | 873 | 869 | 847 | 793 |
| Supplemental Information | – | – | – | – |
| Interest Income | $40 | $36 | $10 | $2 |
| Interest Expense | $3 | $1 | $1 | $1 |
| Depreciation & Amortization | $12 | $8 | $9 | $7 |
| EBITDA | $14 | $67 | -$402 | -$207 |
| % Margin | 2.2% | 8% | -94.3% | -58.2% |